The radius of a blood vessel, and hence the resistance to flow within that vessel, is a result of the dynamic balancing of the blood pressure, which tends to increase radius, against inward forces due to the stretching of the elastic Abbreviation used: VSM, vascular smooth muscle.
Vol. 12 walls and active contraction of the VSM. VSM exerts the force required to resist blood pressure and the shortening required to constrict the blood vessel. Contractility of the intact blood vessel is controlled by a large number of neural and hormonal agents, but at the level of the contractile elements within the cell, control is much simpler.
Ca* + regulates contractility
The major (perhaps only) factor which regulates contractility is the concentration of CaZ + in the vicinity of the contractile elements. This can be directly demonstrated in prep- . Caz + controls VSM contraction Three millimetre lengths of rat tail artery (about 0.5 mm diameter) were mounted between two wires on a tensionmeasuring apparatus and immersed in a continuous flow bath. Circumferential isometric force was measured. The VSM was stretched to its optimum length (160% of rest length) where passive tension was 0.5-0.7g. It was then skinned with Triton X-100 as described by Chatterjee & Murphy (1983) . Skinned VSM was bathed in solution containing imidazole (20mM), potassium acetate (50mhi), MgClz (6mM), dithiothreitol (2mhi), ATP ( 6 m~) , chymostatin (2pg/ml) and leupeptin (2pg/ml). Contraction and relaxation was obtained by varying [CaZ + ] using CaZ+/EGTA buffers. arations of muscle which have been chemically skinned, i.e. cell membranes have been ruptured and soluble material inside the cell washed out, leaving the contractile apparatus intact and in equilibrium with the bathing medium. In such a system (Fig. 1 ) contraction of VSM requires only MgATP as substrate and micromolar Ca2+ concentrations as activator. Reducing the Cat+ concentration results in relaxation of the muscle.
The contractile apparatus is made up of parallel arrays of thick (myosin) and thin (actin) filaments (Murphy, 1979; Marston, 1982) . At the molecular level the mechanism of contraction in all muscles is the same (Marston & Taylor, 1980; Marston, 1983) . Crossbridges arising from the myosin filaments bind to actin and MgATP. The MgATP is hydrolysed at the enzymic site and the energy produced is used to produce a conformational change in the actin-myosin complex resulting in a relative movement of the two filaments (Tregear & Marston, 1979) .
The question 'How is contractility controlled?' may now be restated more specifically as 'How does Cat + control the interaction of myosin and actin?' Cat + can act via receptors on the myosin filaments or the thin (actin-based) filaments or both. A seriesof tests devised by Lehman & Szent-Gyorgyi (1975) may be applied to crude smooth-muscle homogenates to answer this question. Using these it was found that Cat + controlled both thick and thin filament activities .
Mechanism of Cat + regulation of myosin $lament activity
The regulation of myosin's activity has been intensively studied. It was noted early on that in crude actomyosin preparations a component of the myosin molecule, light chain-1, became phosphorylated by an endogenous kinase. Phosphorylation was Cat +-dependent and correlated with the myosin's activity in the intact contractile matrix (by measurement of force production) and in isolated protein preparations (measurement of ATP hydrolysis rate) (for a review see Marston, 1983) . The implication that phosphorylation was necessary for myosin to be active has been tested directly : the actin-activated ATPase activity of pure VSM myosins prepared with varying degrees of phosphorylation correlates only with the level of phosphorylation (Chacko & Rosenfeld, 1982) .
On the basis of this evidence a mechanism for the regulation of VSM myosin by Cat+ has been formulated.
(1) Actin cannot activate myosin activity unless light chain-1 of myosiil is phosphorylated.
(2) Phosphorylation is catalysed by a specific myosin light chain kinase that is activated by Cat + at micromolar concentrations.
(3) Dephosphorylation of myosin and hence inhibition of actomyosin activity is catalysed by a specific phosphatase which is active irrespective of Cat + concentrations.
The effect of phosphorylation on myosin's activity seems to be caused by a modification of the ATP hydrolysis reaction mechanism (Greene et al., 1983; Marston, 1983) . Myosin light chain kinase has been purified (reviewed by Walsh, 1981) . It consists of a 130000-Mr catalytic subunit and one molecule of calmodulin. The catalytic subunit is inactive unless (Cat + ),-calmodulin complex binds : its activity is therefore controlled by Cat+ concentrations in the micromolar range. The quantity present in smooth-muscle tissue is sufficient for complete myosin phosphorylation within 5s.
There is some evidence that in certain circumstances CaZ+ binding to a site on the myosin molecule itself is required in addition to phosphorylation for full activation (Chacko & Rosenfeld, 1982) .
Mechanism of Caz+ regulation of thin $lament's activity
The control of thin-filament activity by Cat + in vascular smooth muscle has been less thoroughly studied than myosin regulation. One reason for the slow progress in this area is the susceptibility of thin-filament preparations to proteolytic attack (Marston & Smith, 1984) . Although the isolation of a possible Cat +-regulated thin-filament preparation from chicken gizzard was reported as long ago as 1975 (Driska & Hartshorne, 1975 ) the isolation and characterization of vascular smooth-muscle thin filaments is recent Marston & Smith, 1984) . Purified sheep aorta thin-filament preparations contain actin, tropomyosin and a 120000-M, protein in weight ratios of 1 :0.4 :0.1 plus small amounts of myosin, filamin and a Ca2 +-binding protein (Fig. 2b) . These thin filaments activate skeletal-muscle myosin MgATPase activity at least 50 times. The activation is Cat+ controlled and exhibits a somewhat complex relationship between the level of activation and the thin-filament concentration, indicative of cooperation interactions between the component proteins (Fig. 2a) . By comparison with the activation due to pure actin or actin plus tropomyosin it is clear that the regulatory factors inhibit activity in the absence of Ca2+ and the inhibition is relieved by Cat + ; half-maximal stimulation requires about 0.5 pM-CaZ +.
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This form of regulation resembles the troponin system of striated muscles. There is no evidence for low-molecularweight proteins corresponding to troponin I and troponin T in the sheep aorta thin filaments, but the 120000-M, protein may perform the same function. We have therefore devised a method of separating and purifying the individual proteins from VSM thin filaments. The essential procedures for purifying the 120000-M, protein is high speed sedimentation in the presence of 0.8M-KCI to separate actin from the other components, an isoelectric precipitation of pH 2.9 which leaves mainly 120000-M, protein in the supernatant and ammonium sulphate fractionation at 40-50% (Fig. 2b) . The 120000-M, protein is extremely sensitive to proteolytic degradation and can be broken down to small components by quantities of trypsin that have no observable effect on actin and tropomyosin.
The purified 120000-Mr protein binds tightly to actin and tropomyosin-actin. It has very little effect on the activity of a skeletal myosin/VSM actin system, but when VSM tropomyosin is present it is a potent inhibitor of the ATPase. Inhibition of up to 90% has been obtained with stoichiometries as low as one 120000-Mr protein per 20-3OVSM actin monomers (Fig. 2c) . Thus the 120000-Mr protein can account for the inhibitory part of the regulatory mechanism; it is, however, usually CaZ + insensitive. A number of smooth-muscle inhibitory proteins have been reported from other sources, though they are of lower molecular weight and may represent fragments of a 120000-Mr protein (reviewed in Marston, 1983) .
In the intact VSM thin-filament regulatory system there is a Ca2+-dependent release of inhibition (Fig. 2a) . In skeletal muscle this function is performed by troponin C. VSM thin-filament preparations contain rather small quantities of proteins resembling troponin-C or calmodulin and it is conceivable that such a protein has been largely lost during preparation. The 120000-Mr protein binds to a calmodulin affinity column in Ca2 + and is released by EGTA so it has the capacity for interaction with a calcium-binding protein. Affinity-column methods are being used to try and recover calcium-binding proteins from VSM preparations.
We have been able to reconstitute a functional Ca2 + regulated thin filament using just four proteins, skeletal muscle actin, VSM tropopmyosin, VSM 120000-Mr protein and brain calmodulin, as Ca2 +-binding proteins (Fig. 26) . This demonstrates in principle the mechanism of Ca2 +-dependent regulation of the VSM thin filament. The 120000-Mr protein inhibits actin, tropomyosin propagates the effect over a large number of actin monomers and Ca2 +<alcium-binding protein complex binds to the 120000 Mr-protein, relieving the inhibition. There are as yet practical difficulties in demonstrating a calcium-sensitive system using all VSM proteins. Under our experimental conditions the 120000-Mr protein binds VSM actin + tropomyosin very tightly indeed (K = 108-109M-1) and inhibition cannot be relieved by brain calmodulin. It is likely that a change of experimental conditions or a native CaZ +-binding protein is required. A similar regulatory mechanism has been proposed for gizzard thin filaments (Kakiuchi & Sobue, 1983) . CaZ + regulation of the whole contractile apparatus and the con-
trol of hypertension
Regulation of the whole contractile apparatus involving multiple Ca2 +-dependent systems is likely to be complex and studies have made little headway in sorting things out. The myosin-phosphorylation system has been investigated in intact blood vessels and it now appears that there is a good correlation between level of myosin phosphorylation and contraction velocity under many conditions but a lack of correlation with the isometric tension in prolonged contractures (Murphy, 1982) . This necessitates the involvement of the other regulatory systems (direct Ca2+ binding to myosin and the thin-filament system). There is as yet no data concerning any changes in these systems which might occur in various forms of hypertension. As for control of hypertension, the biochemical studies have identified proteins which might be targets for drugs (calmodulin, myosin kinase, 120000 M, protein), but there is likely to be a problem of specificity. Regulatory systems in all smooth muscles seem rather similar.
